Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

INTERCEPT | The INTERCEPT™ Blood System by Cerus Corporation
Connect with this vendor - Learn about this product

The INTERCEPT™ Blood System

The INTERCEPT™ Blood System for platelets and plasma uses amotosalen – a well-characterised photoactive compound that specifically targets DNA and RNA – and UVA illumination to irreversibly crosslink nucleic acids. In doing so, INTERCEPT blocks replication of viruses, bacteria, leukocytes and parasites, rendering them inactive.